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Recombinant DNA projects generally involve cell-based gene cloning. However, because template DNA is not always readily
available, in vitro chemical synthesis of complete genes from DNA oligonucleotides is becoming the preferred method for cloning.
This article describes a new, rapid procedure based on Taq polymerase for the precise assembly of DNA oligonucleotides to yield the
complete human fibroblast growth factor 1 (FGF1) gene, which is 468 bp long and has a G+C content of 51.5%. The new method
involved two steps: (1) the design of the DNA oligonucleotides to be assembled and (2) the assembly of multiple oligonucleotides
by PCR to generate the whole FGF1 gene. The procedure lasted a total of only 2 days, compared with 2 weeks for the conventional
procedure. This method of gene synthesis is expected to facilitate various kinds of complex genetic engineering projects that require
rapid gene amplification, such as cell-free whole-DNA library construction, as well as the construction of new genes or genes that
contain any mutation, restriction site, or DNA tag.
1. Introduction
Recombinant DNA projects generally involve cell-based gene
cloning. However, because template DNA is not always
readily available, in vitro chemical synthesis of complete
genes from DNA oligonucleotides is becoming the preferred
method for cloning. This approach is also simpler, more
rapid, and more cost-effective. Recently, several methods
of in vitro gene synthesis have been described, such as
(1) ligation of overlapping single-stranded oligonucleotides
comprising the entire gene followed by PCR amplification
of the crude ligation mixture using two outer primers [1–
3], (2) ligation of preformed duplexes of phosphorylated
overlapping oligonucleotides [4, 5], (3) the Fok I method
[6], (4) the LCR method [7], and (5) single-step gene
assembly from multiple DNA oligonucleotides [8]. Although
long oligomers of up to 300 to 600 bases can be directly
synthesized, the yield is extremely low [9]. Hence, most of
the oligomers in these methods are 25 to 60 nucleotides long
[8, 10, 11].
The cloning of prokaryotic genes is relatively easier than
that of eukaryotic genes because the former do not contain
introns. In fact, eukaryotic genomic DNA cannot be cloned
directly because of introns, and cloning procedures need to at
least include (1) cell culture, (2) isolation of RNA, (3) reverse
transcription from mRNA to cDNA, and (4) amplification
of the cDNA. This conventional method has technological
problems and is expensive and time-consuming, requiring
about 2 weeks to perform [12]. For example, we previously
used this approach to clone the open reading frame of the
human fibroblast growth factor 1 (FGF1) gene, which is
468 bp long and has a G+C content of 51.5% [13]. The source
of the FGF1 gene template was cultured HEK293 cells, from
which total RNA was isolated and then reverse transcribed
with the use of costly extraction kits. Furthermore, after
the nonspecific transcription products were amplified, only
one of the PCR products had the same molecular weight
as FGF1, but it contained mutations. In other words, the
conventional method is inefficient and not cost-effective.
These shortcomings prompted us to consider developing a
new PCR-directed gene synthesis method.
This new method is ligase-free, the oligonucleotides
are designed to cover the complete sequence of both
DNA strands, and the full-length molecule is generated in
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1 GCAACGATGTCATCTCCTCAAACCCGAAGAACATTAAGGGACCTCCGTCTAATTTGAAGAGCCAGTCCCGACACTTCCACCACTAAAGGGGAAGTCGGTA
CGTTGCTACAGTAGAGGAGTTTGGGCTTCTTGTAATTCCCTGGAGGCAGATTAAACTTCTCGGTCAGGGCTGTGAAGGTGGTGATTTCCCCTTCAGCCAT
GGGTGCGAAAGGCGTGACTCGACGTCGACTTACACGACCAGCGAGGACAGGGAACAGGGTAGGTGACACGGTAGGCCTTCCTAGGAGTCCTTCACCGGGG
CCCACGCTTTCCGCACTGAGCTGCAGCTGAATGTGCTGGTCGCTCCTGTCCCTTGTCCCATCCACTGTGCCATCCGGAAGGATCCTCAGGAAGTGGCCCC
CTTGTTTGTAAGGAGTAAACCACAGACACTCGGCATATTTTCGGGCAGCCACAGGTACCGGTTCATGACCGGTCAGAGCCATGAGAAATATATGTGGAGG
GAACAAACATTCCTCATTTGGTGTCTGTGAGCCGTATAAAAGCCCGTCGGTGTCCATGGCCAAGTACTGGCCAGTCTCGGTACTCTTTATATACACCTCC
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GTTTGCAGCTCCCATTCTTCTTGAGGCCAACAAACCAATTCTTCTCTGCATGCTTCTTGGATATATAGGTGTTGTAATGGTTCTCCTCCAGCCTTTCCAG
AATTAGTCTTCTCTGACCGTCCCCCTCTTTGTTCTAACGAAAGACCGGTATCACTCAGGCTCCTGGCG
TTAATCAGAAGAGACTGGCAGGGGGAGAAACAAGATTGCTTTCTGGCCATAGTGAGTCCGAGGACCGC
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Figure 1: Oligonucleotides used to synthesize FGF1. A total of 14 oligonucleotides, 50–70 nucleotides in length, collectively encoded both
strands of the FGF1 gene.
a single step by overlap extension PCR (OE-PCR). Our
protocol is based on the method of Stemmer [8], which
consists of synthesis of oligonucleotides, gene assembly, gene
amplification, and cell-free cloning. Our method uses the
same first and last stages. However, we have combined the
middle two steps (gene assembly and amplification) into
one step: equal volumes of each oligonucleotide solution are
combined and used to generate the full-length template for
gene amplification by PCR using the two outer primers.
2. Materials and Methods
2.1. Oligonucleotides. We designed and ordered 14 oligonu-
cleotides, ranging from 50 to 70 nucleotides in length, which
collectively encoded both strands of the FGF1 gene (Table 1
and Figure 1). The sense and antisense strands each consisted
of 7 oligonucleotides. Complementary oligonucleotides were
expected to overlap when the melting temperature (Tm)
exceeds 60◦C (Figure 1). We incorporated bolded sequences
that overlapped with the parts of the sequence of the plasmid
pcDNA3.1/V5-His-TOPO (Invitrogen, Carlsbad) to facilitate
cloning into this plasmid [13]. Oligonucleotides and all
reagents unless otherwise stated were purchased from Sigma-
Aldrich (St Louis, MO, USA).
2.2. Polymerase Chain Reaction. We synthesized the FGF1
gene using a single-step PCR method by setting up one reac-
tion containing 14 oligonucleotides (4 pmol of each inner
oligonucleotide and 20 pmol of each outer oligonucleotide),
as shown in Figure 1. After the addition of 1 U AccuPrime
Taq High Fidelity polymerase (Invitrogen, Carlsbad), the
reaction was carried out in a PCR thermocycler (Takara Bio,
Shiga, Japan) for 45 cycles at the following cycling profile
settings: 95◦C for 3 minutes, 95◦C for 30 seconds, 49◦C for 1
minute, and 68◦C for 1 minute. The final cycle was followed
by an additional 4 minutes at 68◦C to ensure complete
extension. The holding temperature was 4◦C.
2.3. Assembly of Synthesized FGF1 Gene and pcDNA3.1/V5-
His-TOPO Vector. Single-step DNA assembly and circular-
ization was performed on nonpurified PCR amplification
products by high-fidelity PCR, after the addition of Taq DNA
polymerase [13]. Each 50-μL sample contained 5 μL 10 ×
AccuPrime PCR Buffer I, 0.5 μL of raw reaction product mix
containing the linear vector backbone, 2μL of raw reaction
product mix including the FGF1 gene, and 0.2 μL AccuPrime
Taq High Fidelity. Although the ratio of DNA insert to vector
should change with the size of the fragments, maintaining
the ratio at 4 : 1 for our insert range of 500 bp to 2000 bp
gave satisfactory results. The PCR cycling profile (for 35
cycles) was as follows: 94◦C for 2 minutes, 94◦C for 30
seconds, 52◦C for 30 seconds, and 68◦C for 3 minutes; the
holding temperature was 4◦C. Because the primers included
complementary directional overhangs, the correct head and
tail sequences of the vector and gene were expected to
anneal and assemble into the pcDNA3.1/V5-His-TOPO-
FGF1 plasmid [13].
2.4. Transformation Procedure. One tube containing 50 μL of
DH5α Escherichia coli cells was thawed on ice and 1 μL of
raw reaction product mix from the combined gene assembly
and plasmid insertion step was immediately added and
mixed gently. The tube was then incubated on ice for 30
minutes, heated for 60 seconds in a 42◦C water bath, and
placed on ice for 2 minutes. The contents were added to
950 μL of prewarmed SOC medium (2% tryptone, 0.5%
yeast extract, 0.05% NaCl, 2.5 mM KCl, and 20 mM glucose)
in a 1.5-mL tube and shaken at 225 rpm at 37◦C for 1
hour. Finally, 200 μL was spread onto a prewarmed LB agar
plate containing 100 μg/mL ampicillin, and the plate was
incubated overnight at 37◦C.
Journal of Biomedicine and Biotechnology 3
Table 1: List of oligonucleotides.
Oligonucleotide Sequence (5′ to 3′)
pcFGF1F gtccagtgtggtggaattgcccttaccatggctgaaggggaaatcaccacc
pcFGF1R12-71
TTG TAA TTC CCT GGA GGC AGA TTA AAC TTC TCG GTC AGG
GCT GTG AAG GTG GTG ATT TCC
pcFGF1F42-101 gaagtttaatctgcctccagggaattacaagaagcccaaactcctctactgtagcaacgg
pcFGF1R76-135
TGT GCC ATC CGG AAG GAT CCT CAG GAA GTG GCC CCC
GTT GCTACAGTAGAGGAGTTTGGG
pcFGF1F114-173 gaggatccttccggatggcacagtggatgggacaagggacaggagcgaccagcacattca
pcFGF1R151-210
ATA CAC CTC CCC CAC GCT TTC CGC ACT GAG CTG CAG CTG
AAT GTGCTGGTCGCTCCTGTC
pcFGF1F188-247 cggaaagcgtgggggaggtgtatataaagagtaccgagactggccagtacttggccatgg
pcFGF1R225-284
ACA TTC CTC ATT TGG TGT CTG TGA GCC GTA TAA AAG CCC
GTC GGTGTCCATGGCCAAGTACTGGCCAGTC
pcFGF1F268-327 ggctcacagacaccaaatgaggaatgtttgttcctggaaaggctggaggagaaccattac
pcFGF1R301-360
CTT CTC TGC ATG CTT CTT GGA TAT ATA GGT GTT GTA ATG
GTT CTC CTCCAGCCTTTCCAG
pcFGF1F330-389 cacctatatatccaagaagcatgcagagaagaattggtttgttggcctcaagaagaatgg
pcFGF1R365-424
GGC CAT AGT GAG TCC GAG GAC CGC GTT TGC AGC TCC
CAT TCT TCTTGAGGCCAACAAACC
pcFGF1F402-461 cggtcctcggactcactatggccagaaagcaatcttgtttctccccctgccagtctcttc
pcFGF1R
GCTGGATATCTGCAGAATTGCCCTT TTA ATC AGA AGA
GACTGGCAGGGGG
2.5. Plasmid DNA Extraction. A colony of transformed E. coli
cells was picked and grown in 5 mL LB medium at 37◦C
overnight. Plasmid DNA was extracted with the Plasmid
Miniprep Kit (Sigma-Aldrich, St. Louis, MO, USA).
2.6. Restriction Enzyme Digestion. Double digestion was per-
formed on a sample of extracted plasmid DNA with HindIII
and XhoI (20,000 U/mL and 10,000 U/mL, resp.; New Eng-
land Biolabs, Ipswich, MA, USA). The two restriction sites
were located just beyond either side of the gene. Digestion
products were subjected to agarose gel electrophoresis to
determine the size of the inserted fragment.
2.7. Sequencing. The final plasmid construct was sequenced
by the Genome Research Centre, The University of Hong
Kong, with the ABI BigDye sequencing method, according to
the manufacturer’s instructions (Applied Biosystems, Foster
City, CA, USA).
3. Results
3.1. Synthesis and Assembly of the FGF1 Gene Using PCR. To
clone the FGF1 gene open reading frame (468 bp) into the
pcDNA3.1/V5-His-TOPO vector, we added 27 bp of extra
oligonucleotides to the 5′ end of gene and 25 bp extra
oligonucleotides to the 3′ end, both with sequences identical
to appropriate sites of the vector. The full-length of the
FGF1 fragment obtained from double digestion of the PCR
reaction was 520 bp (Figure 2). The total oligonucleotides
used in the method of Stemmer [8] covered both strands
of the DNA to be synthesized, without any intervening gaps
between individual oligonucleotides. To minimize the cost
of synthesizing oligonucleotides, we left gaps between each
of the 50- to 70-mer oligonucleotides. This strategy allowed
us to use only 14 oligonucleotides, compared with 18 used
by Stemmer. Greater gaps and shorter overlaps resulted in
a 22.22% (4/18) reduction in the cost of synthesizing the
oligonucleotides.
3.2. Cloning and Sequencing of the FGF1 Gene. After the
crude PCR reaction mixtures that contained the product
were directly cloned into the cloning vector, we readily
obtained clones that contained the correct sequences. Double
digestion of extracted plasmid DNA with HindIII and
XhoI yielded two fragments on a 1% agarose gel, of sizes
5433 bp and 561 bp, which represented the linear vector
pcDNA3.1/V5-His-TOPO and the FGF1 gene, respectively
(Figure 3). Because the fragment yielded by HindIII and
XhoI digestion that contained the gene also contained some
base pairs from the vector, it was 31 bp longer than the
corresponding earlier PCR fragment. The DNA sequence of
the FGF1 gene in the complete pcDNA3.1/V5-His-TOPO-
FGF1 construct was 100% in agreement with the sequences
from the NCBI gene bank (data not shown).
4. Discussion
Our goal of improving cloning technology was to reduce the
cost and increase the efficiency of gene synthesis, compared
with the conventional cloning method and the method of
Stemmer [8]. On the basis of the data presented in this
paper, we believe that our protocol of cell-free in vitro gene
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Figure 2: PCR assembly of FGF1. Lane 1: DNA molecular weight
markers. Lane 2: Assembled and amplified FGF1 gene (520 bp).
synthesis offers a simple, rapid, high-fidelity, and low-cost
alternative. The essential feature of our approach is that the
entire gene is synthesized in a single step by PCR. It does
not require the production of a template before the PCR
amplification step. Instead, we combined the two steps of
template formation and full-length product amplification
into one step. The single-step product did not require further
purification and could be directly used for cloning by our
previously published method [13].
Our new method would be very useful in the field of
molecular biology, especially for the cloning of eukaryotic
DNA, because the genes of many eukaryotes contain introns
(several per gene) [14]; for example, FGF1 contains at least
5 introns [15]. We had previously tried to clone the FGF1
gene using cultured human HEK293 cells and human stem
cells and compared the 2 methods [16]. Both cell types
were cultured for at least 2 weeks. Total RNA [17] was
isolated from cells with an RNeasy Mini Kit (Qiagen Sciences,
Germantown, MD, USA). Reverse transcription [18] of
the mRNA was then performed with oligo-(dT) primers
and Moloney murine leukemia virus reverse transcriptase
(Applied Biosystems, Foster City, CA, USA) to generate
the cDNA pool. These procedures required a total of at
least 2 weeks and were costly. Our new 2-day method
would greatly reduce the cost of materials, personnel, and
overheads, and increase the speed by which genes could be
cloned.
The new method would also be useful to readily and
quickly clone genes from viruses [19], bacteria [20] or prions
[21], in a way that would reduce the risk of infection.
In addition, gene expression and cloning in E. coli is a
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Figure 3: Confirmation of assembled plasmid containing the FGF1
gene. The pcDNA3.1/V5-His-TOPO-FGF1 plasmid was cleaved by
HindIII and XhoI. Lane 1: DNA molecular weight markers. Lane 2:
Two digestion fragments of 5433 bp and 561 bp.
standard practice in biomedical research and production.
Because each amino acid relates to more than one codon
[22], gene sequences need to be optimized [23]. Our new
method will help in codon optimization, because a series of
degenerate oligonucleotide sequences can be used, and the
amount of expression of foreign protein in E. coli can be
maximised. Another potential application of our method is
gene shuffling in protein research. Generally, one would have
to choose a group of homologous genes, divide them into
small pieces, recombine them, and select hybrids that yield
improved protein products or that optimize production.
However, it is very difficult to isolate DNA fragments that
have fewer than 50 bp in conventional methods because most
of the fragments are invisible on an agarose gel. Our cloning
method would help in gene shuffling procedures because
gene fragments of the desired size can be prepared and
included reliably in the gene constructs.
In summary, we have developed a protocol that is a
rapid and easy method for gene cloning. This method
of gene synthesis is expected to facilitate various kinds
of complex genetic engineering projects that require rapid
gene amplification, such as cell-free whole-DNA library
construction, as well as the construction of new genes or
genes that contain any mutation, restriction site, or DNA tag.
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